BMO All-Equity ETF Vs. NovoCure Industry Stock Comparison

Sell

45

ZEQT.TO
BMO All-Equity ETF

Last Price:

53.14

Seasonality Move:

4.35%

Buy

75

NVCR
NovoCure

Last Price:

33.40

Seasonality Move:

-5.24%

Sell

45

BMO All-Equity ETF (ZEQT.TO) is a Sell

Is BMO All-Equity ETF a Buy, Sell or Hold?

The current BMO All-Equity ETF [ZEQT.TO] share price is $53.14. The Score for ZEQT.TO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
ZEQT.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

75

NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ZEQT.TO Stock Price Chart

What is BMO All-Equity ETF's stock price today?

The BMO All-Equity ETF share price today is $53.14
The current trend is moderately bullish and ZEQT.TO is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $33.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZEQT.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.54	Buy
Relative Strength Index (14 RSI):	64.2	Buy
Chaikin Money Flow:	-3021	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(51.74 - 53.12)	Buy
Bollinger Bands (100):	(48.15 - 51.91)	Buy

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.78	Buy
Relative Strength Index (14 RSI):	75.34	Buy
Chaikin Money Flow:	1118573	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(16.36 - 28.56)	Buy
Bollinger Bands (100):	(14.7 - 22.78)	Buy

ZEQT.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.25	Sell
20-day SMA:	52.6	Buy
50-day SMA:	51.63	Buy
200-day SMA:	48.27	Buy
8-day EMA:	53.15	Sell
20-day EMA:	52.69	Buy
50-day EMA:	51.68	Buy
200-day EMA:	48.41	Buy

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	29.6	Buy
20-day SMA:	23.68	Buy
50-day SMA:	19.33	Buy
200-day SMA:	17.9	Buy
8-day EMA:	29.53	Buy
20-day EMA:	25.45	Buy
50-day EMA:	21.38	Buy
200-day EMA:	19.88	Buy

BMO All-Equity ETF Earnings Growth & ZEQT.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

BMO All-Equity ETF Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):